CSI-UCSF 2017 , United States of America - Home


September 8 – 9, 2017
San Francisco, USA

CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease - CSI-UCSF 2017 CSI-UCSF 2017 Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2017 , United States of America

CSI-UCSF
September 8 - 9, 2017
San Francisco, USA



Please subscribe to our
csi pfeil
newsletter

Add to my calendar

CSI-UCSF 2017 Topics Program Overview Program Details Training Workshop Scientific Faculty Registration Abstracts & Cases Key Information Supporters Archive Event Calendar
Fontsize bigger
  CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease

Board of Directors

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Neil Wilson, MD

School of Medicine, University of Colorado, Childrens Hospital Colorado
Denver
USA

Board of Directors: Neil Wilson, MD

Randy Lee, MD

University of California
San Francisco
USA

Board of Directors: Randy Lee, MD
More

Randy Lee, MD

University of California
San Francisco, USA

Board of Directors: Randy Lee, MD
Education
1984 UCLA School of Medicine 

Residencies
1988 Harbor-UCLA Medical Center, Internal Medicine
 
Fellowships
1991 Stanford University Medical Center, Cardiovascular Diseases 

Dr. Randall J. Lee graduated from UCLA Medical School in 1984 where he also obtained his doctorate in pharmacology. After completing an internal medicine residency at Harbor-UCLA Medical Center in Torrance, Calif., he completed a cardiology fellowship and postdoctoral fellowship in biochemistry and molecular biology at Stanford University, where he earned a Physician Scientist Award and the Upjohn Young Investigator Award in cardiology. Lee subspecialized in cardiac electrophysiology during his second fellowship at UCSF.
His research focuses on cellular and molecular aspects of cardiac arrhythmias and vascular regeneration. He is investigating the cellular and molecular derangements that occur during cardiac arrhythmias and myocardial infarctions. Lee uses genetic engineering techniques to investigate derangements during cardiac arrhythmias and myocardial infarctions and as possible therapeutic tools. Lee also is interested in cardiac development of the conduction system and the means to alter conduction, which then may be applied to diseased states.

Vaikom Mahadevan, MD

University of California
San Francisco
USA

Board of Directors: Vaikom Mahadevan, MD

Invited Faculty

Theodore P. Abraham, MD

University of California
San Francisco
USA

Invited Faculty: Theodore P. Abraham, MD
More

Theodore P. Abraham, MD

University of California
San Francisco, USA

Invited Faculty: Theodore P. Abraham, MD
Theodore P. Abraham, M.D. is the Meyer Friedman Distinguished Professor of Medicine, Clinical Chief of Cardiology and Director of Echocardiography at the University of California at San Francisco. Until July 2017 he was Professor of Medicine, and Radiology and Radiologic Science at Johns Hopkins University in Baltimore, Maryland where he directed the Johns Hopkins Hospital Echocardiography Programs and founded and directed the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. He was also Associate Dean for Research for Johns Hopkins Medicine. His primary clinical expertise is echocardiography with a focus on cardiac mechanics. He has published over 100 scientific papers, held national leadership positions in professional societies and serves on editorial boards of biomedical journals.

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta
USA

Invited Faculty: Zahid Amin, MD
More

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta, USA

Invited Faculty: Zahid Amin, MD
PRESENT POSITION

Professor of Pediatrics
Chief, Division of Pediatric Cardiology, Children’s Hospital of Georgia, Georgia Regents University, Augusta, GA
FAAP, FSCAI, FACC, FAHA

ACADEMIC APPOINTMENTS
  • 2008 – today Professor of Pediatrics, Director of Cardiac Catheterization & Hybrid Suite, Rush University Medical Center
  • 2006 - 2008 Professor of Pediatrics, University of Nebraska Medical Center
  • 2000 - 2008 Associate Professor of Pediatrics, University of Nebraska Medical Center
  • 2004 - 2008 Associate Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 2000 - 2004 Assistant Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 1998 - 1999 Assistant Professor in Pediatric Cardiology, Medical College of Georgia
CERTIFICATIONS
  • Diplomate, American Board of Pediatrics, January 1996
  • Diplomate, Sub-board of Pediatric Cardiology, August 2002
CONSULTING POSITIONS (active)
  • 2000 – Present The Nebraska Medical Center, Omaha, Nebraska
  • 2000 – 2008 Children’s Hospital, Omaha, Nebraska
HONORS AND AWARDS
  • Session Chair. 4th World Congress of Pediatric Cardiology and Cardiac Surgery.  Buenos Aires, Argentina. 20 Sep 2005.
  • Elected to Honorary Membership in the Russian Scientific Society of Interventional Radiology and Endovascular Surgery. June 2005
  • Best Paper, Awarded by Midwest Pediatric Cardiology Society, 2000.
  • Fellow of the Year, Awarded by Midwest Pediatric Cardiology Society, 1997 – 1998.
  • Outstanding Fellow, Denton A. Cooley Cardiovascular Surgery Society, 1990 – 1992.





                                                                                                                     

Jason Anderson, MD

Mayo Clinic
Rochester
USA

Invited Faculty: Jason Anderson, MD
More

Jason Anderson, MD

Mayo Clinic
Rochester, USA

Invited Faculty: Jason Anderson, MD
Jason Anderson graduated from the University of Iowa Carver College Of Medicine in 2011. He went on to complete his education in Pediatrics and Pediatric Cardiology at Mayo Clinic where he has been appointed to the position of Assistant Professor of Pediatrics in the Mayo School of Graduate Medical Education since 2016. He is now undergoing additional training in pediatric and congenital interventional cardiology under the mentorship of Dr. Philip Moore at UCSF and will return to practice at Mayo Clinic upon completion. Specific interests include transcatheter valve implantation, device closure of septal defects, and intracardiac echocardiography.

Nitish Badhwar, MD

University of California
San Francisco
USA

Invited Faculty: Nitish Badhwar, MD

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis
USA

Invited Faculty: Stefan Bertog, MD
More

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis, USA

Invited Faculty: Stefan Bertog, MD
Specialist in Cardiology, Angiology and Interventional Cardiology at CVC Frankfurt since February 2013

  • Since 2006 Assistant Professor, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
  • 2010 - Present Co-Director of Cardiac Catheterization Laboratory, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2006 - Present Cardiologist, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2003 - 2005 Chief Fellow Cardiology,, University of Minnesota, Minneapolis, Minnesota, USA
  • 2002 - 2006 Fellowship, Cardiology and Interventional Cardiology at University of Minnesota, Minneapolis, USA
  • 1999 - 2002 Residency, Internal Medicine at the Cleveland Clinic Hospital, Cleveland, Ohio, USA
  • 1997 - 1998 Junior Physician, Department of Cardiology at Municipal Hospital in Frankfurt Höchst, Germany
  • 1990 - 1997 Medical Degree at Johann Gutenberg University in Mainz, Germany







Yuval Binur

Arsuf Partners
New York City
USA

Invited Faculty: Yuval Binur
More

Yuval Binur

Arsuf Partners
New York City, USA

Invited Faculty: Yuval Binur
Yuval Binur, Ph.D. is a Managing Partner of Orchestra. He has over 29 years of venture capital experience in the United States, Europe and Israel. Dr. Binur is a co-founder of Accelerated Technologies, Inc. and has served as its Chairman of the Board since its inception in 2001. From 1994 until 2004, he was founding Managing Partner of Medica, a global health care and life sciences venture capital fund operating from Israel. In this capacity, Dr. Binur helped raise Medica's first two venture funds and lead the deployment of approximately $140 million in investments into early stage healthcare technology companies. In 2000, he co-founded and led the financing for PVT, an AT I Portfolio company and the pilot for the Orchestra Strategy. In 2001, he co-founded ATI, and in 2003 he began devoting his full time to his role as Chairman of ATI after the Medica II fund was fully invested.

Dr. Binur participated actively in the sourcing, due diligence, deal structuring, investment execution and monitoring of all of the AT I Portfolio companies. He is currently a director of Mitralign, Vital Access and is also a director of SuperDimension, Ltd., a pioneer in the area of interventional pulmonology. For nine years prior to co-founding Medica, Dr Binur was a Member of Adler & Co., a major U.S. venture capital firm based in New York. He has been a board member of 48 venture-backed companies in the areas of medical technology and devices, pharmaceuticals, software and electronics. Dr. Binur holds a B.Sc. degree in electrical engineering from the Technion Institute in Israel and a Ph.D. degree in physics from MIT/Tel Aviv University.

Todd Brinton, MD

Stanford University
Stanford
USA

Invited Faculty: Todd Brinton, MD
More

Todd Brinton, MD

Stanford University
Stanford, USA

Invited Faculty: Todd Brinton, MD
Todd Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Consulting Associate Professor of Bioengineering at Stanford University. He is an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the Innovation Fellowship Director for Stanford Biodesign since 2005 and also co-directs the Stanford graduate course series in Biodesign Innovation.

Dr. Brinton lectures on strategies for innovation and serves as a mentor to innovation fellows, graduate students, and executives. His academic research focuses on the process of innovation for development of novel medical technologies. He specifically focuses on the integration of research and development for new technologies with the clinical strategy and pre-clinical evaluation. He has served as a clinical investigator for a number to studies of interventional-based therapies for chronic ischemia heart disease and heart failure.

Dr. Brinton completed his medicine, cardiology, and interventional cardiology training at Stanford University. He holds an MD from the Chicago Medical School and a BS in Bioengineering from the University of California, San Diego. He is Co-Founder and Board Director for Shockwave Medical and BioParadox, Inc., which are both venture-backed medical device companies in the cardiovascular space. He also serves on the board of directors of Qool Therapeutics and Infogard Laboratories. In addition, he serves on the advisory board of a number of early-stage medical device companies, where he focuses on clinical development and strategy. Prior to medical school, he was the Clinical Research Director for Pulse Metric, Inc., a venture-backed medical device start-up company.

John Carroll, MD

University of Colorado Hospital
Aurora
USA

Invited Faculty: John Carroll, MD
More

John Carroll, MD

University of Colorado Hospital
Aurora, USA

Invited Faculty: John Carroll, MD
Dr. Carroll received his AB (biology) cum laude from Princeton University in 1972 and his MD (Alpha Omega Alpha) from the University of Chicago in 1976.  He at Tufts New England Medical Center from 1976-1981 finishing as the Samuel Levine Cardiology Research Fellow of the American Heart Association. He then was a cardiology research fellow at Universittaetspital in Zurich, Switzerland. From 1982-1996 he was a member of the faculty at the University of Chicago Pritzker School of Medicine and directed the Hans Hecht Cardiac Catheterization Laboratory. He and his partner, Ted Feldman, started performing aortic and mitral valvuloplasties together starting in 1985. In 1996 he moved to the University of Colorado as Professor of Medicine, Director of Interventional Cardiology, and Co-Medical Director of the Cardiac and Vascular Center.  He has developed the interventional program at the University of Colorado with his partner, John Messenger.

He is currently a member of various national and international editorial and advisory boards, the STS-ACC Transcatheter Valve Therapy Registry Steering Committee, and the Steering Committee of the RESPECT trials.
 
Dr. Carroll is an interventional cardiologist with clinical and investigative interests related to structural/valvular heart disease interventions and the development of advanced cardiac 3D imaging for image guidance. He has collaborated with James Chen, PhD, for over 25 years. Dr. Carroll has co-edited with John G. Webb, MD of Vancouver the first textbook on “Structural Heart Disease Interventions”.

Andrea Colli, MD

University of Padua
Padua
Italy

Invited Faculty: Andrea Colli, MD
More

Andrea Colli, MD

University of Padua
Padua, Italy

Invited Faculty: Andrea Colli, MD
After finishing Medical School at University of Modena and Reggio Emilia, Italy  Dr. Colli’s medical career started with the residency in Cardiac Surgery at University of Parma (2001), Dr. Colli’s career continued in Spain at University of Barcelona with a 2 year fellowship. Dr. Colli’s career continued as Staff Surgeon at Hospital Universitari Germans Trias i Pujol. Dr. Colli Academic and surgical career continued in Padua, Italy as Assistant Professor of Cardiac Surgery (November 2011).

James L. Cox, MD

Northwestern University
Chicago
USA

Invited Faculty: James L. Cox, MD
More

James L. Cox, MD

Northwestern University
Chicago, USA

Invited Faculty: James L. Cox, MD
Dr. Cox is Professor of Surgery and Director, Center for Heart Rhythm Disorders at Northwestern University, Chicago. He received the Distinguished Scientist Award from the AATS, STS, and HRS, was President of the AATS, and is in the Russian Academy of Medical Sciences. Dr. Cox was named one of 30 Pioneers in Cardiothoracic Surgery for the first half century of the specialty by University of Paris in 2000.  Other honors include the Shimert Gold Medal, Fish Award, Ricketts Award, Burakovsky Award, and the Vishnevsky Medal.  Dr. Cox is best known for development of the eponymous “Cox-Maze Procedure” for atrial fibrillation.

Francesca Nesta Delling, MD

University of California, San Francisco
San Francisco
USA

Invited Faculty: Francesca Nesta Delling, MD
More

Francesca Nesta Delling, MD

University of California, San Francisco
San Francisco, USA

Invited Faculty: Francesca Nesta Delling, MD
Dr. Francesca Nesta Delling is a member of the University of California San Francisco (UCSF) Echocardiography Laboratory and an Assistant Professor at UCSF School of Medicine. Her research has focused on mitral valve prolapse and the combined use of echocardiography, cardiac MRI, and molecular genetics as tools to better understand disease mechanisms and progression. She is currently an NIH-funded investigator with ongoing collaborations with the Framingham Heart Study and the Leducq MITRAL Network, an international group of scientists working on mitral valve biology and mechanisms of disease. Dr Delling is also involved in the echocardiographic guidance of Mitraclip procedures.

Paolo Denti, MD

San Raffaele University Hospital
Milan
Italy

Invited Faculty: Paolo Denti, MD
More

Paolo Denti, MD

San Raffaele University Hospital
Milan, Italy

Invited Faculty: Paolo Denti, MD
Responsible of transcatheter therapy for mitral disease as Hybrid Cardiovascular Surgeon since 9/2013 in the Heart Surgery Dept at San Raffaele Hospital, Milan. Adjunct Professor for “Hybrid Cardiac Surgery” and for Master in Interventional Cardiology since 9/2014 at University Vita e Salute, Milan.
Hydrid training in surgical theatre (Prof. Alfieri) and Cath Lab (Prof. Colombo). ESC Fellow and EACTS Member.
Expert Mitraclip implanter (more 100 cases/year). Implanter of 1st Tiara (percutaneous mitral valve) in Italy (2nd Europe). 23/03/2016). 3rd Operator at FIM (First in man) implantation of the first percutaneous annuloplasty band (Cardioband) in 2013 in San Raffaele and Percutaneous Tricuspid valve repair (Tricinch) (2014). Expert on Minimally invasive mitral valve repair included Neochord Transapical implantation, TAVI  (TF, Tap, Tao) either valve in valve mitral and aortic and valve in ring procedures.
Author and co-author of more than 50 papers on peer reviewed journals and book chapters. Honoured of the podium in all renewed international congresses. Involved in sperimental animal surgery and in development of new cardiac devices.
Core interests in innovations, new percutaneous approach to structural heart disease (in particular mitral valve repair and aortic valve implantation), pre-clinical animal/bench study for development of new cardiac devices.

Tobias Deuse, MD

University of California
San Francisco
USA

Invited Faculty: Tobias Deuse, MD
More

Tobias Deuse, MD

University of California
San Francisco, USA

Invited Faculty: Tobias Deuse, MD
Tobias Deuse, M.D. is a cardiac surgeon internationally renowned for his expertise in minimally-invasive mitral valve surgery. He earned an M.D. from University of Wuerzburg in 2000. Dr. Deuse thereafter received advanced training in cardiothoracic surgery at the University Hospital Munich-Grosshadern, the University Heart Center Hamburg-Eppendorf, and Stanford University. He achieved international acclaim for the development of innovative approaches for mitral valve surgery and demonstrated that high success rates can be achieved in endoscopic mitral valve repair even for complex valve pathologies. He is the Director for Minimally-invasive Cardiac Surgery at UCSF.

Shephal Doshi, MD

Saint John's Health Center, Pacific Heart Institute
Santa Monica
USA

Invited Faculty: Shephal Doshi, MD

Gan Dunnington, MD

St Helena Hospital
St. Helena
USA

Invited Faculty: Gan Dunnington, MD

Danny Dvir, MD

University of Washington
Seattle
USA

Invited Faculty: Danny Dvir, MD
More

Danny Dvir, MD

University of Washington
Seattle, USA

Invited Faculty: Danny Dvir, MD
Danny Dvir has large experience in structural heart interventions. He is the president of the board of the Institute of Valvular Research and is internationally recognized as an expert in evaluating and treating prosthetic heart valves, including valve-in-valve therapy. Dr. Dvir was trained in Internal Medicine and Cardiology in Israel. Subsequently, he had Cardiac Interventions fellowship training in in Washington DC and later on worked extensively and specialized in non-invasive strategies for the treatment of heart valves in the Center for Heart Valve Innovation in Vancouver, BC. Dr. Dvir is a faculty in the University of Washington.

Christopher Ellis, MD

Vanderbilt Heart and Vascular Institute
Nashville
USA

Invited Faculty: Christopher Ellis, MD

Marvin Eng, MD

Henry Ford Health System
Detroit
USA

Invited Faculty: Marvin Eng, MD
More

Marvin Eng, MD

Henry Ford Health System
Detroit, USA

Invited Faculty: Marvin Eng, MD
Marvin H. Eng MD graduate from Wayne State School of Medicine and completed his internal medicine and general cardiology training at the University of Colorado Health Sciences Center. Subsequently, Dr. Eng completed his interventional cardiology training at the Scripps Clinic in La Jolla, California.  His first faculty appointment was at the University of Texas Health Sciences Center-San Antonio where he started the TAVR program at the University.  Since arriving back in Detroit in 2015, Dr. Eng currently serves as the Structural Heart Disease (SHD) Fellowship and the SHD research director.  His focus includes imaging, large bore access, TAVR and mitral interventions.   

Jesse Esch, MD

Boston Children’s Hospital / Harvard Medical School
Boston
USA

Invited Faculty: Jesse Esch, MD
More

Jesse Esch, MD

Boston Children’s Hospital / Harvard Medical School
Boston, USA

Invited Faculty: Jesse Esch, MD
Dr. Esch completed medical school in his native Canada, and pursued residency at the Stollery Children’s Hospital (University of Alberta). After completing pediatric cardiology fellowship and senior fellowship in interventional cardiology at Boston Children’s Hospital, he joined the faculty there in 2013. His research interests include structural interventions for pulmonary hypertension, invasive assessment of physiology in congenital heart disease, intracoronary delivery of novel agents for myocardial protection/recovery, and adverse events in pediatric interventional cardiology. He is actively involved in teaching residents and fellows, and is an Instructor in Pediatrics at Harvard Medical School.

Ted Feldman, MD

Evanston Hospital
Evanston
USA

Invited Faculty: Ted Feldman, MD
More

Ted Feldman, MD

Evanston Hospital
Evanston, USA

Invited Faculty: Ted Feldman, MD
Dr. Feldman received his undergraduate and medical training at Indiana University, completing residency training as Chief Resident at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. After finishing his Cardiology Fellowship at the University of Chicago, he remained there as Professor of Medicine and Director of the Cardiac Catheterization Laboratory.

He currently practices at Evanston Hospital, where he is Director of the Cardiac Catheterization Laboratory, holds the Walgreen Chair in Interventional Cardiology, and is Professor of Clinical Medicine at University of Chicago Medical School.

He has authored over 500 manuscripts, chapters, abstracts, and editorials and edited or co-edited several books. He is a Percutaneous Coronary Intervention Guideline co-author and has served on the American Board of Internal Medicine Interventional Cardiology test writing committee. Chicago Magazine has repeatedly named him among Chicago’s Top Doctors.

Dr. Feldman is a past-President of the Society of Cardiovascular Angiography & Interventions, and chaired the Annual Scientific Sessions of the Society, as well as the American College of Cardiology Interventional Sessions.

He is an active interventional practitioner and performs hundreds of catheter procedures every year. He has been the national principal investigator of the EVEREST MitraClip trial and the REPRISE III TAVR trial, and participates in numerous clinical investigations, with major research interests that include non-surgical, percutaneous repair of the mitral valve, catheter based aortic valve replacement, shunt closure for congenital heart disease, left atrial appendage closure, and development of new catheter devices.

Paul Friedman, MD

Mayo Clinic
Rochester
USA

Invited Faculty: Paul Friedman, MD
More

Paul Friedman, MD

Mayo Clinic
Rochester, USA

Invited Faculty: Paul Friedman, MD
Dr. Paul Friedman is a Professor of Medicine and Vice-Chair of the Department of Cardiovascular Medicine at Mayo Clinic, Rochester, Minnesota, and Vice-Chair for Academic Affairs and Faculty development.  He is ABIM board certified in cardiovascular medicine and cardiac electrophysiology, and is an active participant in the MOC process.

Previously, Dr. Friedman served as Director of the Cardiac Implantable Device Lab, Mayo Clinic.  He is a trained electrical engineer, with deep experience in innovation (> 40 patents issued, named Minnesota Top Inventor), and scientific research (> 250 scientific original publications).  He is a committed educator, serving as a director for 5 national and international meetings, editor of 7 textbooks, and author of over 60 book chapters.  He is a frequent visiting professor and lecturer at educational meetings.

Dr. Friedman received his BA in Plan II liberal arts and BS in Electrical Engineering from the University of Texas at Austin.  He received his medical degree from Stanford University, and trained in internal medicine at the University of Washington, Seattle (internship) and Stanford University.  He trained in cardiovascular medicine and cardiac electrophysiology at Mayo Clinic, Rochester, MN.

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle
USA

Invited Faculty: Sameer  Gafoor, MD
More

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle, USA

Invited Faculty: Sameer  Gafoor, MD
Attending Physician

Dr. Sameer Gafoor is an attending physician at the CardioVascular Center (CVC) Frankfurt headed by Horst Sievert, MD. He obtained his medical degree from Northwestern University in the United States, followed by Internal Medicine Residency at University of michigan. His cardiology training started with Cardiovascular Disease Fellowship at Washington Hospital Center/Georgetown University and continued with Interventional Cardiology Fellowship at Emory University.

Following this training, he went on to complete an Advanced Fellowship in Neurovascular, Coronary, Structural Heart, and Peripheral Vascular Training at the CVC Frankfurt. He specializes in interventions and imaging for structural heart and peripheral vascular disease, as well as development and incorporation of new devices, technologies, and techniques for these and other indications.

Achille Gaspardone, MD

Ospedale San Eugenio
Rome
Italy

Invited Faculty: Achille Gaspardone, MD

Edward P. Gerstenfeld, MD

University of California
San Francisco
USA

Invited Faculty: Edward P. Gerstenfeld, MD

Eberhard Grube, MD

University Hospital Bonn
Bonn
Germany

Invited Faculty: Eberhard Grube, MD
More

Eberhard Grube, MD

University Hospital Bonn
Bonn, Germany

Invited Faculty: Eberhard Grube, MD
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.

Julius Guccione

University of California
San Francisco
USA

Invited Faculty: Julius Guccione

David Holmes, MD

Mayo Clinic
Rochester
USA

Invited Faculty: David Holmes, MD
More

David Holmes, MD

Mayo Clinic
Rochester, USA

Invited Faculty: David Holmes, MD
Dr. Holmes is currently a Professor of Medicine at the Mayo Clinic College of Medicine and a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Holmes has also been named the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine in Honor of Dr. George M. Gura, Jr.  He was awarded an Honorary Fellowship of the Royal College of Physicians in Ireland in November 2011.  He has received the Distinguished Scientist Award (Clinical Domain) from the American College of Cardiology and the Research Career Achievement Award from the Mayo Graduate School of Medicine.  He is a Past President of the American College of Cardiology (ACC) as well as the Society for Cardiac Angiography and Interventions (SCAI).  He has lectured widely both nationally and internationally.  He has received the Herrick Award from the American Heart Association.     

His special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, and risk outcomes analysis.  In addition, he has been involved in the development of new catheter designs for stroke prevention using left atrial appendage occlusion technology.  He has been involved with the introduction and dispersion of transcatheter aortic valve replacement in the United States working with both ACC and the Society for Thoracic Surgery (STS).  As part of that, he has been involved with regulatory agencies including FDA and CMS.  This collaboration has led to the development of a working group on Early Feasibility Studies (EFS).  Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds.

Dr. Holmes received his medical degree at Medical College of Wisconsin in Milwaukee and completed his internship at Virginia Mason Hospital in Seattle.  He also served in the United States Navy at the National Naval Medical Center in Bethesda.

Michael Hope, MD

University of California
San Francisco
USA

Invited Faculty: Michael Hope, MD
More

Michael Hope, MD

University of California
San Francisco, USA

Invited Faculty: Michael Hope, MD
Michael D. Hope, MD, is an Associate Professor in Residence in the Department of Radiology at UCSF. He obtained his medical degree from Stanford in 2004. The following year, he did a Medicine internship at California Pacific Medical Center. Dr. Hope completed his Diagnostic Radiology residency at UCSF in 2009, followed by a fellowship in Cardiopulmonary Imaging. He is the Co-Director of the Vascular Imaging Research Center at UCSF, Chair of the MR Safety Committee, and increasingly recognized as an expert in advanced cardiovascular imaging techniques with over 50 invited lectures and 70 peer-reviewed papers, which have been cited over 1,700 times.

Dr. Hope was recently awarded an R01 grant entitled, "Hemodynamic and inflammatory imaging in evaluation of abdominal aortic aneurysms" (R01HL123759). His long-term goal is to expand significantly the role of MR vessel and blood flow imaging in the clinical management of patients with cardiovascular disease.

Expertise:
Cardiac, Aortic and Pulmonary Imaging

Specialty:
Advanced Aortic Imaging
4D Flow Vascular Imaging

Professional Interests:
MR vessel wall and blood flow imaging in the clinical management of patients with cardiovascular disease

Education and Training:
• Medical School: Stanford University School of Medicine, California
• Internship: California Pacific Medical Center, San Francisco
• Residency: University of California, San Francisco
• Fellowship: University of California, San Francisco - Cardiopulmonary Imaging
• California Medical License
• American Board of Radiology, Certificate in Diagnostic Radiology

Jonathan Hsu, MD

University of California, San Diego
La Jolla
USA

Invited Faculty: Jonathan Hsu, MD
More

Jonathan Hsu, MD

University of California, San Diego
La Jolla, USA

Invited Faculty: Jonathan Hsu, MD
Dr. Jonathan Hsu is an Assistant Clinical Professor of Medicine at UCSD School of Medicine, Division of Cardiology.  His primary clinical interest is in cardiac electrophysiology, and he specializes in both the medical and procedural care of patients with all types of heart rhythm disturbances.  
Dr. Hsu is also a clinical research investigator with formal advanced training (Master’s Degree) in clinical research methods and biostatistics.  His research focuses on the epidemiology and clinical outcomes in patients with all types of cardiac arrhythmias and devices, including reducing the risk of stroke in atrial fibrillation patients with oral anticoagulants and reducing complications in implantable-cardioverter defibrillator recipients.  Dr. Hsu is also actively involved in formal didactic teaching at the UCSD School of Medicine, and is dedicated to the education mission of UCSD through instruction of medical students, residents, and fellows.
Dr. Hsu is specially trained in catheter ablation to treat arrhythmias such as supraventricular tachycardia (including atrial fibrillation) and ventricular tachycardia in addition to implantation and management of cardiac rhythm devices including pacemakers, implantable-cardioverter defibrillators, and cardiac resynchronization therapy (biventricular) devices.  He is specially trained in performing left atrial appendage occlusion and left atrial appendage ligation for stroke risk reduction in patients with atrial fibrillation.
Dr. Hsu has a special clinical interest in quality of cardiovascular care improvement and outcomes research.  He has specific expertise in Registry and large database analyses to improve the medical and procedural care of patients with arrhythmias.
Dr. Hsu completed fellowship training in general cardiology and received additional advanced sub-specialty training in cardiac electrophysiology at the University of California, San Francisco (UCSF), where he also completed his Master’s Degree in Clinical Research (MAS).  He completed both his internship and residency at Massachusetts General Hospital.  He earned his undergraduate and medical degree at Northwestern University.

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal
Canada

Invited Faculty: Reda Ibrahim, MD
More

Reda Ibrahim, MD

University of Montreal, Institut of Cardiology
Montreal, Canada

Invited Faculty: Reda Ibrahim, MD
Dr Reda Ibrahim is a cardiologist at the Montreal Heart Institute and an Associate Professor at the University of Montreal. He studied Internal Medicine and Cardiology at the University of Montreal. In 2001-2002, he conducted a subspecialty in adult congenital and structural interventions at the Brigham and Women and Children's Hospitals of Harvard University in Boston. Dr. Ibrahim is the Medical Director of the Structural Heart Diseases Program since 2014 and is the former Director of the Medical Intensive Care Unit (2006-2014). He has won several awards and honors including the professor of the year from the Department of Medicine in 2004 and 2005. In term of research, he was the principal investigator of several important studies (CLOSURE-1, PC-trial, RESPECT, PRIMA, REDUCE, etc.). As other achievements, he has many publications, numerous presentations in major congresses (TCT, EuroPCR, PICS, CSI, AHA, ACC-i2 Summit, ESC), a number of Canadian and North American premieres, live proceedings at various conferences (ACC-TCT-EuroPCR-PICS-ISLAA), and "proctor" activities for different companies.

Srinivas Iyengar, MD

Manatee Memorial Hospital
Bradenton
USA

Invited Faculty: Srinivas Iyengar, MD
More

Srinivas Iyengar, MD

Manatee Memorial Hospital
Bradenton, USA

Invited Faculty: Srinivas Iyengar, MD
Dr. Iyengar was born and raised in New Jersey an attended Rutgers University. He followed this with medical school at Ross University, with subsequent Internal Medicine training (including a year as Chief Resident) at the Jewish Hospital/University of Cincinnati. Dr. Iyengar completed a year of Heart Failure/Transplantation under the tutelage of Dr. William Abraham at the Ohio State University. This was then followed by a two-year advanced interventional cardiology/peripheral vascular fellowship at Columbia University. He then joined Bradenton Cardiology Center in Florida where he serves currently as the Structural Heart Director of Manatee Memorial Hospital. Dr. Iyengar has authored numerous peer reviewed manuscripts and book chapters. He has performed hundreds of TAVR, mitraclip, and Watchman/LAA occlusion device procedures over the last five years and is currently very active in structural cardiology device research.

Hasan Jilaihawi, MD

NYU Langone Medical Center
New York
USA

Invited Faculty: Hasan Jilaihawi, MD
More

Hasan Jilaihawi, MD

NYU Langone Medical Center
New York, USA

Invited Faculty: Hasan Jilaihawi, MD
Hasan Jilaihawi, MD, is an Interventional Cardiologist,
and Associate Professor of Medicine and Cardiothoracic Surgery at NYU Langone Medical Center. He also directs the NYU Imaging Corelab and is Co-Director of Transcatheter Valve Therapies. He is heavily involved in all aspects of clinical cardiology, with a special interest in innovative methods of imaging the heart, complex percutaneous coronary intervention and device and patient selection for transcatheter aortic valve replacement (TAVR) and other heart valve therapies. In 2007, he was one of the two cardiologists who performed the first TAVR procedure in the United Kingdom.

Samir Kapadia, MD

Cleveland Clinic
Cleveland
USA

Invited Faculty: Samir Kapadia, MD
More

Samir Kapadia, MD

Cleveland Clinic
Cleveland, USA

Invited Faculty: Samir Kapadia, MD
Samir Kapadia, MD, is the Section Head of Invasive and Interventional Cardiology, the Director of the Sones Cardiac Catheterization Laboratories, and Director of the Interventional Cardiology Fellowship Program in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology.
Specialty/Clinical interests: Percutaneous treatment for valve disease, transcatheter aortic valve replacement (TAVR), Mitraclip, complex coronary interventions, atrial septal defect (ASD) and patent foramen ovale (PFO) closure, carotid interventions, peripheral interventions

Number of Procedures Performed: Dr. Kapadia has performed 1,000 TAVR procedures and thousands of other cardiovascular procedures throughout his career.

Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at: http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx

Education and Training: Dr. Kapadia received his medical degree with honors from Smt. NHL Municipal Medical College in Gujarat, India. He completed his internship and residency in internal medicine at Baylor College of Medicine, Houston, where he was named Outstanding Resident. Dr. Kapadia completed fellowships in cardiology and interventional cardiology at Cleveland Clinic, Cleveland, and was named Chief Interventional Fellow. Dr. Kapadia was appointed to Cleveland Clinic in 2003 as a Staff Interventional Cardiologist.
Prior to his appointment to Cleveland Clinic, Dr. Kapadia had an academic appointment to the Department of Medicine at the University of Washington, Seattle, and was an Interventional Cardiologist at the VA Puget Sound Health Care System, Seattle.
Research, Publications and Speaking: Dr. Kapadia has published more than 300 articles and abstracts in professional scientific journals.

About Dr. Kapadia: “I love to get to know the patients and families well so that I can provide appropriate care and meet their expectations. Procedural expertise is necessary for the best outcomes but not enough; compassionate clinical care is an essential element that we should not ignore.”

Leisure time activities: In his leisure time, Dr. Kapadia enjoys spending time with his family, astronomy, physics, and math.

Saibal Kar, MD

Cedars Sinai Medical Center
Los Angeles
USA

Invited Faculty: Saibal Kar, MD

Ahmed Kheiwa

University of California
San Francisco
USA

Invited Faculty: Ahmed Kheiwa

Susheel Kodali, MD

Columbia University Medical Center
New York City
USA

Invited Faculty: Susheel Kodali, MD
More

Susheel Kodali, MD

Columbia University Medical Center
New York City, USA

Invited Faculty: Susheel Kodali, MD
Susheel K. Kodali, MD is the director of the Heart Valve Center at NY-Presbyterian/ Columbia University Medical Center. Dr. Kodali is also the director of the interventional cardiology fellowship program and an associate professor in medicine at CUMC.

Board certified in internal medicine, interventional cardiology, endovascular medicine, and cardiovascular disease. Dr. Kodali specializes in the percutaneous treatment of coronary artery and structural heart disease, and cardiac catheterization.

Dr. Kodali was named New York Metro Area’s Top Doctor in 2012, 2013, 2014, 2015, 2016 & 2017 by Castle Connolly's Top Doctors™ and New York Magazine’s Top Doctors in 2012, 2013 and 2014. Dr. Kodali serves as the institutional co-investigator of the PARTNER trials and associated registries as well as the principal investigator for the Sentinel Trial.
Dr. Kodali attended medical school at The University of California, Los Angeles. He did his residency and a fellowship program in clinical cardiology at the University of California, San Francisco, and a fellowship program in interventional cardiology at Columbia University Medical Center.

Ilya Kovalchuk, MD

City Center of Interventional Cardioangiology
Moscow
Russia

Invited Faculty: Ilya Kovalchuk, MD
More

Ilya Kovalchuk, MD

City Center of Interventional Cardioangiology
Moscow, Russia

Invited Faculty: Ilya Kovalchuk, MD
          After successful completion of residency, in 2007, I made the first steps in endovascular surgery. Step by step, I mastered theoretical and practical skills of selective coronary angiography and coronary angioplasty in patients with chronic coronary artery disease and in patients with Acute Myocardial Infarction.

          For several years I accumulated experience in endovascular interventions, learning new techniques in intravascular imaging and engaging in scientific work. Including writing a PhD thesis, actively attending and making presentations at leading scientific conferences in Russia, Europe and USA. Since 2010 we have started endovascular procedures on the aortic valve as well as endovascular treatment of congenital heart defects (ASD) in Moscow City Centre of Interventional Cardioangiology. I am deeply engaged in this problem. I started my scientific work to become a MD, with my topic being Endovascular Closure of Atrial Septal Defect in adults.

          My particular interest is the technology of coronary stenting with use of bioresorbable stents, including patients with AMI. In addition, with the improvement techniques of the transcatheter aortic valve implantation in patients with high-risk surgery, the emergence of new devices and reduction delivery system, it would be very interesting for me to take an active part in carrying out such operations using various stents with different approaches. The same applies to transcatheter mitral valve implantation, as such operations are not preformed in our Center. With regard to structural heart disease intervention - this is my greatest interest at the moment. I would be interested to learn the operation of the left atrial appendage closure in patients with atrial fibrillation that I have seen performed in the hospitals in Israel, as well as the closure of ASD, as it is the subject of my doctoral work. I work in a clinic specializing in the treatment of coronary heard disease, therefore the operations on the carotid and peripheral arteries are no more than 100 a year which prevents me from gaining much needed experience as a doctor in this field.

         As for my personal qualities, during my time working I have proved to be conscientious, resourceful worker in the scientific and practical sphere of the Centre, benevolent towards colleagues and patients. I am familiar with clinical methods of examination and treatment of patients.

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat
Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
More

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat, Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
●    Post graduate teacher in cardiology in Medical Colleges of Kerala. 1983 – 1991
●    Consultant at  the first comprehensive paediatric cardiac service in UAE at the Mafraq Hospital, Abu Dhabi, 1991 – 2004
●    Head of Paediatric Cardiology  at The Madras Medical Mission, Chennai and Frontier Lifeline, Chennai,India. 2004 – 2014
●    Course Director  at Advanced Cardiovascular Therapeutics, The Madras Medical Mission, Chennai. 2006 – 2012 .
●    Invited Speaker ,UCSF Cardiology Grand Rounds,April 13.2016
●    Author of over 30 publications and several text book chapters.
●    E-teacher for paediatric cardiology residents worldwide

Raj Makkar, MD

Cedars-Sinai Medical Center
Los Angeles
USA

Invited Faculty: Raj Makkar, MD

Rebecca Mandel, MD

Lucid Care
Tampa
USA

Invited Faculty: Rebecca Mandel, MD

Jeffrey Meadows, MD

UCSF Benioff Children’s Hospital
San Francisco
USA

Invited Faculty: Jeffrey Meadows, MD
More

Jeffrey Meadows, MD

UCSF Benioff Children’s Hospital
San Francisco, USA

Invited Faculty: Jeffrey Meadows, MD
Dr. Meadows is a pediatric cardiologist who specializes in interventional cardiac catheterization procedures in infants, children and adults with complex congenital and acquired heart disease. Dr. Meadows is Director of the Pediatric & Congenital Cardiac Catheterization Laboratory at the UCSF Benioff Children’s Hospital where he also serves as Director of the Pediatric Cardiopulmonary Exercise Testing Program.
 Dr. Meadows is an associate professor in the UCSF Division of Pediatric Cardiology. He earned a medical degree at Johns Hopkins University and completed an internship and residency in pediatric internal medicine and fellowships in pediatric cardiology and pediatric interventional cardiology at Children's Hospital in Boston. Dr. Meadows as also completed advanced training in biostatistics and clinical study design through the UCSF Department of Epidemiology and Biostatistics.

Suneet Mittal, MD

Valley Hospital
New York
USA

Invited Faculty: Suneet Mittal, MD
More

Suneet Mittal, MD

Valley Hospital
New York, USA

Invited Faculty: Suneet Mittal, MD
Dr. Mittal earned his BA and MD degrees from Boston University. He did his Internal Medicine residency and Cardiology fellowship at the Hospital of the University of Pennsylvania. He then completed a fellowship in Electrophysiology at Weill Cornell Medical Center. He is currently the Director of the Electrophysiology Laboratory at The Valley Hospital in New Jersey. Dr. Mittal’s active research interests include the role of implantable monitors in patients with known or suspected arrhythmias and overcoming barriers to remote patient monitoring. He serves as the Heart Rhythm Society’s Co-Ambassador to India. He is currently an Editorial Board member of Circulation Arrhythmia and Electrophysiology, Heart Rhythm and the Journal of Interventional Cardiovascular Electrophysiology.

Philip Moore, MD

University of California
San Francisco
USA

Invited Faculty: Philip Moore, MD

Gareth Morgan, MD

University of Colorado
Denver
USA

Invited Faculty: Gareth Morgan, MD
More

Gareth Morgan, MD

University of Colorado
Denver, USA

Invited Faculty: Gareth Morgan, MD
Gareth Morgan was appointed as a consultant congenital interventional cardiologist at Evelina Children’s Hospital and Guys and St Thomas’ hospital in London in June 2013.

Gareth’s subspecialty fellowship in interventional congenital cardiology was carried out with Dr Lee Benson at the Hospital for Sick Children, Toronto, Ontario 2008-2010.

He was first appointed consultant paediatric and adult congenital cardiologist at University Hospitals Bristol in 2010 and has been an honorary senior lecturer at the University of Bristol since 2011.

Gareth's undergraduate and early postgraduate training was at The Queens University of Belfast and the Royal Belfast Hospital for Sick Children.

Here he also completed his MPhil research thesis in paediatric cardiology before SpR training in paediatric and adult congenital cardiology at University Hospitals Bristol.

Joshua Moss, MD

University of California
San Francisco
USA

Invited Faculty: Joshua Moss, MD
More

Joshua Moss, MD

University of California
San Francisco, USA

Invited Faculty: Joshua Moss, MD
As a clinical cardiac electrophysiologist, I have expertise in catheter ablation techniques for complex arrhythmias, including ventricular tachycardia, supraventricular tachycardia, atrial fibrillation, and atrial flutter.  I am also skilled in surgical implantation of pacemakers, defibrillators, and biventricular devices.  I currently lead or participate in multiple clinical studies on existing and evolving techniques for treating patients with arrhythmias and congestive heart failure, including those with a ventricular assist device (VAD). Trained as an engineer prior to beginning my medical career, I also maintain an active research interest in novel device design for advanced cardiac rhythm management

Mubashir Mumtaz, MD

Pinnacle Health System
Harrisburg
USA

Invited Faculty: Mubashir Mumtaz, MD
More

Mubashir Mumtaz, MD

Pinnacle Health System
Harrisburg, USA

Invited Faculty: Mubashir Mumtaz, MD
Dr. Mumtaz has practiced in the Central Pennsylvania area since 2002.  He currently serves as the Chief of Cardiovascular & Thoracic Surgery at Pinnacle Health System since June of 2010 and is also the Surgical Director of the Pinnacle Health Structural Heart and Valve Clinic.  Under his direction, the Pinnacle Health Program has achieved three star ratings in all three categories (CAB only, AVR only, CAB/AVR only) and has maintained three star rating for CAB only for 7 consecutive rating periods.

Dr. Mumtaz completed his surgery residency at the University of Connecticut and Cardiothoracic fellowship at Penn State Milton S. Hershey Medical center.  He received advanced training at the Cleveland Clinic.

He is Board Certified by the American Board of Surgery and the American Board of Thoracic Surgery.

Specialties include mininally invasive surgery for valvular disease including transcatheter, robotic and right chest approaches; Total Thoracoscopic MAZE for atrial fibrillation; Coronary and Aortic Surgeries.

Anthony Nobles

HeartStitch, Inc.
Fountain Valley
USA

Invited Faculty: Anthony Nobles
More

Anthony Nobles

HeartStitch, Inc.
Fountain Valley, USA

Invited Faculty: Anthony Nobles
Chairman of The Board & CEO of HeartStitch, Inc.

Anthony Nobles is a medical professional, engineer, inventor, entrepreneur, professor and philanthropist. Over the past 28 years, he has developed and patented more than 150 products and medical devices. He specializes in vascular and cardiovascular devices, and his inventions have assisted surgeons around the world in successfully performing complex suturing and cardiac surgeries.

Nobles has founded several medical technology companies and currently serves as the Chairman and CEO of HeartStitch Medical, Inc. and Nobles Medical Technologies II, Inc. One of his earlier business ventures, Nobles Medical Technologies I, was sold to Medtronic in 2010. He also founded Sutura, which he took public in 2005.

Professor Nobles currently holds over 40 patents and has been a contributing author for various medical publications on a variety of surgical topics. He travels all over the world training surgeons and physicians in the procedures he has personally developed. With over 28 years of clinical and operating room experience, he is recognized worldwide as an expert in his field.

His career successes have afforded him the ability to make considerable contributions to charities and local community initiatives. The Nobles Family helped to fund the Sunset Beach Community Center, which was renamed the Nobles Family Community Building in appreciation for their efforts. Professor Nobles also delights local residents by organizing and personally funding an elaborate Halloween extravaganza that has attracted 30,000 in the past.

Outside of his professional and philanthropic efforts, Professor Nobles is an avid car enthusiast and Formula 1 race car driver.

Prof. Nobles has invented over 150 medical devices and holds multiple patents and trademarks for technologies from electronics and medical devices to automotive technologies. Prof. Nobles has lectured and presented around the world at the American college of Cardiology, the Society of vascular Surgery, the American College of Neurosurgery, Congress on Congenital & Structural Interventions, Paris meeting on Revascularizations, Harvard Medical School, USC School of Healthcare, UCLA Medical School, University of Zwickau and many other congresses and schools. Prof. Nobles recently became a Professor of Biomedical Science at the West Sachsen University Zwickau, Germany.

Allan Nugent

Children’s Health Dallas
Dallas
USA

Invited Faculty: Allan Nugent
More

Allan Nugent

Children’s Health Dallas
Dallas, USA

Invited Faculty: Allan Nugent
Dr Nugent trained in pediatrics and pediatric cardiology at the Royal Children’s Hospital in Melbourne Australia and completed fellowship in pediatric cardiology at Boston Children’s Hospital. He is currently the Director of Catheterization at Children’s Health Dallas and an Associate Professor Department of Pediatrics at UT Southwestern Medical Center. At UTSW he has been the lead investigator in testing biodegradable stents for congenital heart disease applications.

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo
Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
More

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo, Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
•    Medical Degree with honours
University of Milan, Milan School of Medicine, Italy (1977)
University of Zulia, Maracaibo School of Medicine, Venezuela (1980)

•    First Class Degree Certification, Cardiology
Post Graduate Course in Cardiology, University School of Medicine, Caracas, Venezuela (1984)

•    Degree Certification, Paediatric Cardiology
Post Graduate Course in Pediatric Cardiology, University School of Medicine, Caracas, Venezuela (1986)

•    Teaching Assistant Professor
Institute of Cardiology, University Hospital of Caracas, Venezuela (1985-1989)

•    Degree Certification, Radiology
Post Graduate Course in Radiology, University School of Medicine, Siena, Italy (1994).

•    Co-Director of the Cardiovascular Catheterization Laboratory
Centro "E. Malan", San Donato Hospital, University of Milan, Italy (1989-1997)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Clinica San Rocco di Franciacorta, Ome, (Brescia), Italy (1997-2002)

•    Director of Cardiology Division I and Cardiac Catheterization Laboratory
Humanitas Gavazzeni Clinic, Bergamo, Italy (2002-2006)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Ospedale Sant’Orsola Fatebenefratelli, Brescia, Italy (2006-2009)

•    Teaching Professor, Interventional Cardiology
  Policlinico Universitario Tor Vergata, University School of Medicine, Rome (2010 - 2011)

•    Current position:  Consultant , Interventional Cardiology, Congenital and Structural Heart Diseases
Cardiovascular Department, Humanitas Gavazzeni Clinic, Bergamo
Senior Consultant, Centro Cardiologico Monzino, University School of Medicine, Milan, Italy



•    Scientific Consultant, Proctor and Trainer, Congenital and Structural Interventional Cardiology;
•    Scientific Consultant, Proctor and Trainer, Intracardiac Ultrasound for catheter-based interventional procedures
Centro Cardiologico Monzino, University School of Medicine, Milan, Italy
    Clinica Montevergine, Mercogliano, Italy
    S.Anna Hospital, Catanzaro, Italy
    Presidio Ospedaliero San Giovanni di Dio, Agrigento
    Presidio Ospedaliero “S.Elia”, Caltanissetta
    Bakulev Scientific Center for Cardiovascular Surgery, Moscow Medical Academy, Russian Federation
    Republican Cardiology Center – Ufa, Republic of Bashkiria, Russian Federation
    Cardiology Institute, Kazan, Republic of Tatarstad, Russian Federation
    Cardiology Dept, Santariskiu Klinikos, University School of Medicine, Vilnius, Lithuania
    Centru Cardiovascular, Spitalul Monza – Bucarest, Romania
    Hungarian Institute of Cardiology – Pediatric Cardiac Centre – Budapest, Hungry
    Instituto de Cardiologia, Hospital Universitario de Caracas, University School of Medicine – Caracas, Venezuela
    Instituto Cardiovascular de Buenos Aires, Argentina
    Servicio de Cardiologia – Hemodinamia, Hospital de Los Valles – Quito, Ecuador
    Om El Kora Cardiac Center, University Hospital, Tanta, Egypt
    Pediatric Cardiology, Cairo University Children Hospital, Egypt
    Centre Hospitalier Universitaire (CHU) “Charles Nicole, Rouen, France
    Centre Hospitalier Universitaire (CHU) “Arnaud de Villenueve“, Montpellier, France
    Centre Hospitalier Régional Universitaire de Lille (CHRU), France
    American Heart Institute, Nicosia, Cyprus  



Scientific Society Memberships
National
•    Società Italiana di Cardiologia Pediatrica (SICP)
•    Gruppo Italiano di Studi Emodinamici e Cardiologia Interventistica (G.I.S.E.)
•    Associazione Medici Cardiologi Ospedalieri (A.N.M.C.O.): Fellow
•    Società Italiana di Radiologia Medica (SIRM)
International
•    Sociedad Venezolana de Cardiologia
•    Sociedad Latina de Cardiologia Pediatrica
•    The Society for Cardiac Angiography and Interventions (SCAI): Fellow
•    European Society of Cardiology (ESC): Fellow
•    Russian Scientific Society of Interventional Radiology & Endovascular Surgery: Honorary Membership
•    Sociedad Venezolana de Cardiologia Intervencionista : Honorary Membership


Field of Interest and Clinical Research
Interventional Percutaneous Procedures in Congenital and Structural Heart Diseases in Childrens and Adults:
-    Interatrial communications: atrial septal defect and patent foramen ovale (PFO) closure
-    Ventricular sepal defect closure (perimembranous, muscular)
-    Post-infarction ventricular septal rupture closure  
-    Patent ductus arteriosus closure
-    Pulmonary arteriovenous malformations and coronary artery fistulas closure
-    Paravalvular Leak percutaneous closure
-    Left Atrial Appendage Closure  
-    Balloon Valvuloplasty for pulmonary valve and aortic valve stenosis
-    Other complex congenital heart defects

Augusto Pichard, MD

MedStar Washington Hospital Center
Washington, DC
USA

Invited Faculty: Augusto Pichard, MD
More

Augusto Pichard, MD

MedStar Washington Hospital Center
Washington, DC, USA

Invited Faculty: Augusto Pichard, MD
Augusto D. Pichard, MD, is Director Emeritus of the Cardiac Catheterization Laboratories and former Director of Innovation and Structural Heart Disease at Medstar Washington Hospital Center in Washington, DC.
Dr Pichard built 11 Cardiac Cath Labs at the MWHC, known for high quality, efficiency and scientific achievements; with the highest procedural volume and scientific output in the world during many years. He also built 3 Hybrid OR/Cath Labs for the performance of complex structural heart disease procedures, and created a sophisticated Structural Heart Team. Additionally, he is  a committed academician and is a Professor of Medicine (Cardiology) at Georgetown University. He is a dedicated teacher and has trained many physicians in the Cath Labs who are now leaders in the specialty around the world; he received the J. Lindsay Award for Best Teacher.
Dr. Pichard is active in clinical research. His research expertise is in Invasive Cardiology, including coronary angioplasty, intracoronary imaging and physiology, percutaneous valve repair and replacement. In addition, he trains American and international cardiologists in the percutaneous treatment of coronary and structural heart disease. He has been the PI for numerous trials.
Dr Pichard travels extensively lecturing about his specialty, and is a recognized international leader in Interventional Cardiology.
Dr. Pichard is Board Certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. He has written more than 700 manuscripts for peer-reviewed journals on numerous topics in Cardiology. He also is active in national and international educational activities related to his specialty. Dr. Pichard serves on several editorial boards and is a Fellow of numerous professional organizations, both in the United States and abroad. He is a founder Fellow of the Society for Cardiac Catheterization and Interventions (SCAI) and was a trustee of that Society.
Dr Pichard graduated with highest honors from the Catholic University of Chile. He completed Cardiology Fellowship at the Cleveland Clinic (1971-3) and stayed on Staff at the Cleveland Clinic until 1975. He was Director of the Cath Labs at Mount Sinai Hospital New York 1975-81; and started Coronary Angioplasty at that Institution. He took a Sabbatical at the Catholic University in Chile 1982, where he initiated Angioplasty and a Clinical Research Program. He came to Washington in 1983 as Director of the Cath Labs at the Washington Hospital Center and Professor of Medicine of the George Washington University.
Dr Pichard had been very active in numerous Boards at the Medstar Washington Hospital Center, including the Hospital Board of Directors, Foundation Board, Medical and Dental Staff Board, WHC Research Board, Washington Cardiology Center Board, and Vice Chair of the Heart and Vascular Institute.

Atif N. Qasim, MD

University of California
San Francisco
USA

Invited Faculty: Atif N. Qasim, MD

John F. Rhodes, Jr., MD

Miami Children’s Health System
Miami
USA

Invited Faculty: John F. Rhodes, Jr., MD
More

John F. Rhodes, Jr., MD

Miami Children’s Health System
Miami, USA

Invited Faculty: John F. Rhodes, Jr., MD
Dr. Rhodes is “The Heart Program”, Medical Director for Pediatric Cardiology and the Adult Congenital Heart Program at Miami Children’s Hospital.  Prior to joining Miami Children’s, Dr. Rhodes served as chief for the Duke Clinical Heart Program and Duke Children’s Heart Center in Durham, North Carolina.  He was also co-director of the Duke Adult Congenital Heart Program.  
Dr. Rhodes received his medical degree from The Brody School of Medicine in Greenville, North Carolina and completed his fellowship in cardiology at The Mount Sinai Medical Center in New York.  He pursued additional training in interventional catheterization for children and adults at The Cleveland Clinic Foundation in Cleveland.  
Dr. Rhodes’ clinical interests involve diagnostic and interventional catheterization procedures for children and adults with complex congenital heart disease.  He has helped pioneer several techniques, including transcatheter atrial septal closure with the Gore Helex Septal Occluder, intracardiac echocardiographic imaging to guide catheter interventions, cutting balloon angioplasty of stenotic branch pulmonary arteries, and pulmonary vein stenosis following radiofrequency ablation of atrial fibrillation.  He is currently the National Principal Investigator for the REDUCE trial for the management of patent foramen ovale in the setting of cryptogenic stroke and is an investigator for trials including the new Gore Septal Occluder device, Edwards Lifesciences pulmonary stent valve, MELODY pulmonary stent valve, and covered stent angioplasty for coarctation of the aorta.

Campbell Rogers, MD

HeartFlow, Inc
Redwood City
USA

Invited Faculty: Campbell Rogers, MD
More

Campbell Rogers, MD

HeartFlow, Inc
Redwood City, USA

Invited Faculty: Campbell Rogers, MD
Dr. Rogers brings a wealth of experience to HeartFlow, where he serves as the Executive Vice President and Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA. He received his A.B. from Harvard College and his M.D. from Harvard Medical School.

Carlos E. Ruiz, MD

Hackensack University Medical Center and The Joseph M. Sanzari Children's Hospital
Hackensack
USA

Invited Faculty: Carlos E. Ruiz, MD

Scott Russell

Emboline, Inc.
Santa Cruz, CA
USA

Invited Faculty: Scott Russell

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver
Canada

Invited Faculty: Jacqueline Saw, MD
More

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver, Canada

Invited Faculty: Jacqueline Saw, MD
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Associate Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She served as Head of VGH Cardiology Clinical Trials Research. She is an active physician proctor for LAA closure with WATCHMAN and ACP/Amulet devices.

Dr. Saw is a pioneer in research and management of spontaneous coronary artery dissection (SCAD) and is the PI of the CIHR-funded multi-center prospective Canadian SCAD Study. Other research interests include LAA closure, coronary fibromuscular dysplasia, antiplatelet therapy, carotid artery stenting, peripheral arterial disease and intervention. She is also PI of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has co-authored over 130 peer-reviewed publications, and is the editor of three textbooks on LAA closure and carotid artery stenting.

Nelson B. Schiller, MD

University of California San Francisco
San Francisco
USA

Invited Faculty: Nelson B. Schiller, MD
More

Nelson B. Schiller, MD

University of California San Francisco
San Francisco, USA

Invited Faculty: Nelson B. Schiller, MD
Dr. Nelson B. Schiller is a cardiologist specializing in the use of echocardiography in the diagnosis and treatment of heart disease. He is the founder of the UCSF Echocardiography Laboratory and the UCSF Adult Congenital Heart Disease Clinic. He has played an integral role in the development of many diagnostic and treatment techniques including two dimensional echocardiography, transesophogeal echocardiography, Doppler pulmonary pressure determination, myocardial contrast perfusion and echocardiography phase imaging for ventricular coordination. In structural heart disease areas, he is an expert in the treatment of mitral and aortic valve diseases, hypertrophic cardiomyopathy and congenital heart diseases.

In collaboration with his colleagues, his research interests includes in quantitation of cardiac function and structure, the biology and function of the left atrium, exercise physiology and hemodynamics in heart disease, body composition in heart disease, adult congenital heart disease, three-dimensional reconstruction, echocardiographic contrast agents for quantitation and myocardial perfusion, transesophageal echocardiography, physiology of renal disease, and outcomes in coronary disease as predicted by quantitative phenotyping.

Van Selby, MD

University of California
San Francisco
USA

Invited Faculty: Van Selby, MD

Warren Sherman, MD

LoneStar Heart, Inc.
Irvine
USA

Invited Faculty: Warren Sherman, MD
More

Warren Sherman, MD

LoneStar Heart, Inc.
Irvine, USA

Invited Faculty: Warren Sherman, MD
Dr. Sherman has been a leader in the field of regenerative medicine and interventional cardiology, focusing on delivery methods of biotherapeutics for HF, STEMI and consulting widely for NIH, CIRM, industry and other entities.  In 2014 he transitioned from CIVT Director of Stem Cell Research and Regenerative Medicine at Columbia University Medical Center, where he directed the Annual International Conference on Cell Therapy for Cardiovascular Diseases (IC3D), to industry, where he is now CMO of LoneStar Heart, Inc.

Kolja Sievert

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Invited Faculty: Kolja Sievert

Paul Teirstein, MD

Scripps Clinic
La Jolla
USA

Invited Faculty: Paul Teirstein, MD
More

Paul Teirstein, MD

Scripps Clinic
La Jolla, USA

Invited Faculty: Paul Teirstein, MD
Dr. Paul Teirstein is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. He received training at The Mount Sinai School of Medicine, The Brigham and Women’s Hospital, Stanford University, the Mid-America Heart Institute and the National Institutes of Health, Dr. Teirstein joined Scripps in 1987 and is the founder and director of the interventional cardiology training program at Scripps Clinic.
With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents.  Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR)
The author of numerous publications, Dr. Teirstein has lectured throughout the world on state-of-the-art interventional cardiology techniques. He is an internationally recognized leader in cardiology and has received countless awards for both research and clinical excellence. Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
He is also a member of multiple professional societies including the American Heart Association, the Society of Cardiac Angiography and Interventions and is a fellow of the American College of Cardiology. Dr. Teirstein recently founded the National Board of Physicians and Surgeons (NBPAS), a not-for-profit organization providing an alternative pathway for physician certification that ensures compliance with national standards and promotes lifelong learning (NBPAS.org).

David R Tschopp, MD

Texas Cardia Arrhythmia
Austin
USA

Invited Faculty: David R Tschopp, MD
More

David R Tschopp, MD

Texas Cardia Arrhythmia
Austin, USA

Invited Faculty: David R Tschopp, MD
Dr. Tschopp graduated from the University of Wisconsin School of Medicine in 1997.  After completing his Internal medicine training at UCSF he went on to complete Cardiology Fellowship at The Cleveland Clinic and Electrophysiology Fellowship at the University of Michigan.
He is currently Electrophysiologist partner at Texas Cardiac Arrhythmia in Austin TX.   He specializes in conduction disorders and arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia, and supraventricular tachycardias.  He performs complex catheter ablation, LAA ligation and occlusive procedures for prevention of embolic stroke associated with atrial fibrillation in addition to implanting devices.  
He has interests in investigational devices and drugs for the treatment of cardiac arrhythmias.

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford
USA

Invited Faculty: Mintu P. Turakhia, MD
More

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford, USA

Invited Faculty: Mintu P. Turakhia, MD
Associate Professor
Executive Director, Center for Digital Health
Stanford University School of Medicine

Chief of Cardiac Electrophysiology, VA Palo Alto Health Care System

Mintu Turakhia M.D. M.A.S. is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. In his clinical role as Chief of EP at the VA, Dr. Turakhia performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders. Dr. Turakhia has an active, highly-funded multidisciplinary program in Atrial Fibrillation, where uses large datasets to examine quality, outcomes, and risk prediction for heart rhythm disorders. As the Executive Director of Stanford’s new Center for Digital Health, he is the principal investigator of several multi-center trials to test digital health tools and wearable devices to screen and manage heart rhythm disorders. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.

Stephan von Bardeleben, MD

Heart Center Mainz
Mainz
Germany

Invited Faculty: Stephan von Bardeleben, MD

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit
USA

Invited Faculty: Dee Dee Wang, MD
More

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit, USA

Invited Faculty: Dee Dee Wang, MD
Dee Dee Wang, M.D., FACC, FASE, FSCCT  specializes in Interventional Imaging in Structural Heart Interventions including Transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures.
Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging for high-risk Structural Heart Interventions. She is currently the Director of Structural Heart Imaging at Henry Ford Hospital’s Center for Structural Heart Disease, Medical Director of 3D Printing at Henry Ford Innovations Institute, and Director of the  CT CoreLab at Henry Ford Hospital’s Center for Structural Heart Disease.

Wei Wang, MD

Peking Union Medical College, Chinese Academy of Medical Science
Beijing
China

Invited Faculty: Wei Wang, MD
More

Wei Wang, MD

Peking Union Medical College, Chinese Academy of Medical Science
Beijing, China

Invited Faculty: Wei Wang, MD
POSITIONS
Professor and Chief Director
Department of Structural Heart Disease
Ward 53, Department Cardiac Surgery
Fuwai Hospital, Peking Union Medical College

EDUCATION
Cardiac Surgery Residency from Fuwai Hospitals
01/1984 - BeiJing, China
Visiting Scholar from Hyogo College of Medicine
10/1989 - Osaka, Japan
Visiting Scholar from The University of Tennessee
09/1999 - Knoxville, Tennessee,United States
M.D. from Peking Union Medical College
06/1998 – Beijing,China
B.S. from Peking University
08/1984 - Beijing,China

Dr. Wei. Wang specializes in the clinical evaluation and treatment of valvular diseases and structural heart diseases, including surgical repair, replacement and transcatheter intervention of valvular diseases. He was the PI of J-Valve China Trial and continues to immerse himself in evolving approaches to transcatheter aortic implantation through surgical access.

David Wilber, MD

Loyola University Medical Center
Maywood
USA

Invited Faculty: David Wilber, MD
More

David Wilber, MD

Loyola University Medical Center
Maywood, USA

Invited Faculty: David Wilber, MD
David Wilber, MD, FAHA, FACC, George M. Eisenberg Professor of Medicine and director, Electrophysiology Section and Cardiovascular Institute, Loyola University Medical Center. Dr. Wilber received his medical degree from Northwestern University Medical School and completed his residency in Internal Medicine at Northwestern Memorial Hospital. He completed his fellowship in cardiovascular disease at the University of Michigan Hospitals and a fellowship in Clinical Cardiac Electrophysiology at Massachusetts General Hospital. His career clinical and research interests have focused on risk stratification and prevention of sudden cardiac death, and mechanisms and ablation of ventricular tachycardia and atrial fibrillation. He has been named annually to Top Doctors in Chicago and the US since 2001. Dr. Wilber is the author or coauthor of more than 500 original articles, book chapters and abstracts, and has served on the steering committee for several multicenter clinical trials.

Jim Wudel, MD

CHI Health Nebraska Heart
Lincoln
USA

Invited Faculty: Jim Wudel, MD
More

Jim Wudel, MD

CHI Health Nebraska Heart
Lincoln, USA

Invited Faculty: Jim Wudel, MD
Dr Jim Wudel is a cardiac and thoracic surgeon with over twenty years experience in the area of structural heart disease(SHD).  After completing his training at UCSF and the Cleveland Clinic Foundation, he joined the Nebraska Heart Institute in Lincoln, NE.  He quickly became part of the heart failure and cardiac transplant program and was a co-investigatior in the landmark REMATCH LVAD trial for end stage heart failure. He has extensive experience in the surgical therapy for functional mitral regurgitation and has been a principal investigator for the ACORN, Myocor, and COAPT trials. His practice has transitioned  to a focus on transcatheter therapies for SHD including TAVR, TMVR and MitraClip.  He is active in the investigational evaluation of the Ancora Heart percutaneous ventriculoplasty system for functional mitral regurgitation and heart failure.

Yongquan Xie, MD

Fuwai Hospital, National Center for Cardiovascular Disease
Beijing
China

Invited Faculty: Yongquan Xie, MD
More

Yongquan Xie, MD

Fuwai Hospital, National Center for Cardiovascular Disease
Beijing, China

Invited Faculty: Yongquan Xie, MD
Dr. Yongquan Xie, M.D. is a surgeon who works in Cardiovascular Surgery Dept of Fuwai Hospital, the National Center For Cardiovascular Disease of China. He got his doctor degree in Peking United College in 2000. From May 2008 to May 2009, he has been a visiting doctor in Cardiothoracic Surgery Department of University of Southern California and worked with Dr. Von Starnes. He has been trained for more than 22 years of cardiac surgery and catheter intervention. He is interested in Cardiac Surgery, surgical and catheter therapy of structural cardiac disease. He has finished more than 1000 cases of cardiac surgery and catheter intervention therapy. Dr. Xie specialized in CABG, valvular repair and replacement, surgical repair or transthoracic and transcatheter occlusion of ASD, VSD and PDA.
CSI   CSI
Contact Data Privacy Imprint Home CSI 2017